Gene · 4855
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Somatic mutations in facial skin from countries of contrasting skin cancer risk. | Nat Genet | 2023 | 37537257 | PubTator, text mining | PubMed |
| Organoid-Based Human Stomach Micro-Physiological System to Recapitulate the Dynamic Mucosal Defense Mechanism. | Adv Sci (Weinh) | 2023 | 37525340 | PubTator, text mining | PubMed |
| Targeting CD301+ macrophages inhibits endometrial fibrosis and improves pregnancy outcome. | EMBO Mol Med | 2023 | 37519221 | PubTator, text mining | PubMed |
| Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells. | Pharmaceuticals (Basel) | 2023 | 37513851 | PubTator, text mining | PubMed |
| A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer. | Medicina (Kaunas) | 2023 | 37512088 | PubTator, text mining | PubMed |
| Pulsed Electromagnetic Fields (PEMF)-Physiological Response and Its Potential in Trauma Treatment. | Int J Mol Sci | 2023 | 37510998 | PubTator, text mining | PubMed |
| Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review. | Genes (Basel) | 2023 | 37510267 | PubTator, text mining | PubMed |
| LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy. | Biomedicines | 2023 | 37509517 | PubTator, text mining | PubMed |
| Landscape of Genetic Mutations in Appendiceal Cancers. | Cancers (Basel) | 2023 | 37509254 | PubTator, text mining | PubMed |
| Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting. | Curr Issues Mol Biol | 2023 | 37504302 | PubTator, text mining | PubMed |
| Meis1 establishes the pre-hemogenic endothelial state prior to Runx1 expression. | Nat Commun | 2023 | 37500618 | PubTator, text mining | PubMed |
| Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas. | Acta Neuropathol | 2023 | 37495858 | PubTator, text mining | PubMed |
| JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1. | Genes Dis | 2023 | 37492742 | PubTator, text mining | PubMed |
| Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications. | Front Cell Dev Biol | 2023 | 37492224 | PubTator, text mining | PubMed |
| Immunohistochemical Evaluation of Notch1 in Ovarian Tumours and Its Prognostic Implications. | Cureus | 2023 | 37489207 | PubTator, text mining | PubMed |
| Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond. | Immunooncol Technol | 2023 | 37483658 | PubTator, text mining | PubMed |
| NOTCH4 potentiates the IL-13 induced genetic program in M2 alternative macrophages through the AP1 and IRF4-JMJD3 axis. | Int Immunol | 2023 | 37478314 | PubTator, text mining | PubMed |
| Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications. | Front Oncol | 2023 | 37476370 | PubTator, text mining | PubMed |
| Retracted: Zizhu Ointment Accelerates Wound-Healing of Diabetic Ulcers through Promoting M2 Macrophage Polarization via Downregulating the Notch4 Signaling Pathway. | Comput Intell Neurosci | 2023 | 37476261 | PubTator, text mining | PubMed |
| Differential roles of regulatory T cells in acute respiratory infections. | J Clin Invest | 2023 | 37463441 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4855/papers?page=15